Abiopharma

🔍 BACON KENNETH J (Executive)

Company: WELLTOWER INC. (WELL)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Acquired 2,627 shares of Common Stock (Direct)
  Date: 2026-05-01 | Code: C | equity_swap_involved: false | shares_owned_after: 14,306.00 | transaction_form_type: 4
• Sold 2,627 shares of OP Units (Derivative)
  Date: 2026-05-01 | Code: C | equity_swap_involved: false | shares_owned_after: 3,591.00 | transaction_form_type: 5 | Footnotes: F1, F1, F1, F1

Footnotes:

• F1: (1) On February 23, 2023, the reporting person received an award of membership interests in Welltower OP LLC ("Welltower OP"), a subsidiary of Welltower Inc. (the "Issuer"), designated as LTIP Units ("LTIP Units"), which were subsequently converted, upon both vesting and the satisfaction of minimum allocations to the capital accounts of the LTIP Units for federal income tax purposes, into Class A Common Units in Welltower OP ("OP Units") that are exchangeable for shares of common stock, par value $1.00 per share ("Common Shares"), of the Issuer or the equivalent cash value of Common Shares, as determined by the Issuer. On May 1, 2026, these OP Units were exchanged for Common Shares.